Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TDS, FVT

Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference


COLOGNE, Germany, Jan. 31, 2023 /PRNewswire/ -- Singleron Biotechnologies, a leader in single cell sequencing, will present at the upcoming 36th Molecular Biology of Plants 2023 (MBP2023) Conference of the Section Plant Physiology and Molecular Biology of the German Society for Plant Sciences (DBG) in Hennef, Germany (February 6-9, 2023).

Singleron's single cell workflow and tools can not only investigate how biotic and abiotic interactions affect intrinsic cell mechanisms but can also unravel the genetic networks and the cellular crosstalk of complex tissues and identify essential signaling pathways during development or stressed conditions. Singleron will be showcasing their latest single cell multi-omics solutions based on the innovative SCOPE-chip® microwell technology and its flexible configurations that enable high capture rates of fragile protoplasts and nuclei.

The effectiveness of these solutions will be presented in a talk given by Dr. Eva Maleckova entitled "Single-cell sequencing: the new era of (transcript)omics." Dr. Maleckova will be presenting the latest single cell methods for plant research, demonstrating the advantages of Singleron's technologies.

About Singleron

Founded in 2018, Singleron develops and commercializes single cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single cell analysis. The company currently has offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in over 2000 laboratories in hospitals, research institutes, and pharmaceutical companies.

Media Contact
Email: [email protected]

 

SOURCE Singleron Biotechnologies GmbH


These press releases may also interest you

at 19:22
In testimony to the California State Assembly Committee on Health, the National Coffee Association today (April 16) detailed the safety and health benefits of decaffeinated coffee and strongly opposed a last-minute shift that proposes misleading...

at 18:30
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice President and Chief Medical Officer. In addition, after four...

at 18:16
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 17:56
The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.  The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12%...

at 17:45
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to...

at 17:31
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...



News published on and distributed by: